Malignant Hemopathy
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells (NCT04517656) | Centre Hospitalier Universitaire de Saint Etienne | 2022-05-25 |
| COVID-19 Related Lockdown Effects On Chronic Diseases (NCT04390126) | Centre Hospitalier Universitaire Dijon | 2020-04-14 |
| Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03965429) | Institut Paoli-Calmettes | 2019-05-14 |
| Validation of Radio-induced Damage Biomarkers (NCT02999152) | Centre Hospitalier Universitaire de Saint Etienne | 2017-06-22 |
| Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents (NCT01574235) | Hospira, now a wholly owned subsidiary of Pfizer | 2011-10-01 |
| Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia (NCT00190463) | Assistance Publique - Hôpitaux de Paris | 2003-04-01 |
Track Malignant Hemopathy automatically
Every clearance here is in the API, with alerts when new ones post.